Multimedia

Alison Conlin, MD, MPH, medical oncologist, Providence Cancer Institute, stresses the importance of research in breast cancer care and says the stressors and outcomes of the pandemic share similarity to those of a cancer-related outcomes.

Petros Grivas, MD, PhD, discusses results from a study exploring decision-making processes regarding first-line treatment choices, testing practices and treatment eligibility determinants for patients with metastatic urothelial cancer.

Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...

Nimira Alimohamed, MD, discusses results from a real-world analysis of outcomes over time in patients with muscle-invasive bladder cancer and patients with metastatic urothelial carcinoma.

Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors on overall survival among patients with metastatic urothelial carcinoma in real-world practice.

William Rayford Gwin III, MD, medical oncologist, Seattle Cancer Care Alliance, breaks down some common challenges in treating breast cancer that make it unique compared to other types of cancer, and provides some risk reducing strategies for...

Danny Sanchez, vice president and general manager, EnlivenHealth, speaks about the benefits of the CareScheduler tool; outlines how it improves processes for pharmacists, health plans, and patients; as well as highlights how this kind of...

Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...